Your session is about to expire
← Back to Search
Weight Loss Incentives for Obesity
N/A
Waitlist Available
Led By Corrine I Voils, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Able to stand for weight measurements without assistance
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 26, 52, and 78 weeks
Awards & highlights
Study Summary
This trial will test whether giving people weekly incentives to monitor their diet and/or lose weight leads to better short- and long-term weight loss. The study will last 18 months.
Who is the study for?
This trial is for adults with obesity who want to lose weight. They must be able to stand unassisted, have a BMI of 30 or higher, speak and read English, own a smartphone with data and texting plans, have reliable internet access, and commit to attending study visits over an 18-month period.Check my eligibility
What is being tested?
The study tests if small weekly incentives can boost dietary self-monitoring and weight loss effectiveness. Participants will use apps like MyFitnessPal and Fitbit daily while receiving these incentives for their progress over the course of the trial.See study design
What are the potential side effects?
Since this trial involves lifestyle changes rather than medication, side effects are not typical as in drug trials. However, participants may experience stress or frustration related to diet tracking or meeting weight loss goals.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can stand on my own for weight checks.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 26, 52, and 78 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 26, 52, and 78 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent of participants who achieve clinically significant weight loss of at least 5 percent of baseline weight at 26 weeks
Secondary outcome measures
Change in diastolic blood pressure from baseline to 26, 52, and 78 weeks
Change in dose equivalents of cardiovascular medications from baseline to 78 weeks
Change in systolic blood pressure from baseline to 26, 52, and 78 weeks
+2 moreOther outcome measures
Extrinsic motivation for weight loss as assessed by modified Treatment Self-Regulation Questionnaire
Intrinsic motivation for weight loss as assessed by modified Treatment Self-Regulation Questionnaire
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Weight lossExperimental Treatment1 Intervention
Weekly incentives for weight loss
Group II: Dietary self-monitoringExperimental Treatment1 Intervention
Weekly incentives for dietary self-monitoring
Group III: CombinedExperimental Treatment1 Intervention
Weekly incentives for dietary self-monitoring and weight loss
Group IV: ControlActive Control1 Intervention
Find a Location
Who is running the clinical trial?
University of Wisconsin, MadisonLead Sponsor
1,182 Previous Clinical Trials
3,166,687 Total Patients Enrolled
28 Trials studying Obesity
7,820 Patients Enrolled for Obesity
Duke UniversityOTHER
2,358 Previous Clinical Trials
3,419,369 Total Patients Enrolled
81 Trials studying Obesity
31,069 Patients Enrolled for Obesity
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,833 Previous Clinical Trials
47,305,796 Total Patients Enrolled
251 Trials studying Obesity
205,356 Patients Enrolled for Obesity
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can attend all required study visits in person.I can stand on my own for weight checks.I have not had unstable heart disease in the last 6 months.I am not taking high doses of certain water pills except for potassium-sparing ones.You have severe memory problems, misuse drugs or alcohol, or have a mental illness that is not well controlled.I have lost 5 lbs or more in the last month.My kidney function is severely reduced.I have difficulty hearing.I cannot do mild or moderate exercise due to pain, fainting, or another condition.I want to lose weight.You need to score at least 4 out of 6 on a test that checks your thinking and memory abilities.You are currently participating in a program that helps you change your lifestyle to manage your weight.I have had or plan to have weight loss surgery during the study.I have had fluid removed from my abdomen before.I can join a video call with a device that has a camera and microphone.I am currently taking medication to lose weight.I have not been treated for cancer (other than skin cancer) in the last 6 months.You can use the MyFitnessPal and Fitbit apps every day by downloading and using them on your phone or other devices.I use insulin or certain diabetes medications.I experience chest pain or shortness of breath when I exert myself.
Research Study Groups:
This trial has the following groups:- Group 1: Combined
- Group 2: Dietary self-monitoring
- Group 3: Weight loss
- Group 4: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Obesity Patient Testimony for trial: Trial Name: NCT04770909 — N/A
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment currently recruiting participants?
"That is correct. Per records on clinicaltrials.gov, this medical trial has been actively looking for participants since May 13th 2021 and was revised as recently as October 10th 2022. In total, 700 patients are required from two different sites to complete the study's requirements."
Answered by AI
What is the upper limit for patient participation in this experiment?
"Affirmative. Per the information stored on clinicaltrials.gov, this experiment is actively recruiting participants with a date of posting of May 13th 2021 and an update from October 10th 2022. The trial requires 700 individuals to be recruited from 2 distinct medical facilities."
Answered by AI
Who else is applying?
What state do they live in?
Wisconsin
Indiana
North Carolina
How old are they?
65+
18 - 65
What site did they apply to?
Duke University Medical Center
University of Wisconsin-Madison
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
0
3+
Why did patients apply to this trial?
I have tried for 6 years to lose weight and have not been successful. I thought I would try a trial to help others, but to also help myself.
PatientReceived 1 prior treatment
I've been trying for 20+ years to lose weight...fad diets, exercise, lifestyle changes, doctors, weight loss programs, pills, etc. Some methods worked better than others but I have never come close to achieving my goal weight. While I have been able to lose over 100lbs over a 4 year period, I am still struggling, and am, in fact, gaining again. The excess weight is affecting my daily life like it never has before and I need help.
PatientReceived 2+ prior treatments
What questions have other patients asked about this trial?
How long do the screenings take, and are they done over the telephone?
PatientReceived 2+ prior treatments
How responsive is this trial?
Typically responds via
Email
Most responsive sites:
- Duke University Medical Center: < 24 hours
- University of Wisconsin-Madison: < 24 hours
Average response time
- < 2 Days
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger